# Space Bio-Laboratories Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/space-bio-laboratories-co

- Industry: Medical Devices & Equipment
- Headquarters: Hiroshima-shi, Japan
- Website: www.spacebio-lab.com/
- Total disclosed funding: $0.9M
- Latest round: Series A (Jun 24, 2020)
- Investors on record: 2

## About

Based in Hiroshima, Japan, established in 2005, Space Bio-Lab carries out research and development, manufacturing, sales, and export/import for gene, cell, medicinal products, reagents, and medical materials for clinical and research use, research and development, manufacturing, sales, export/import for medical equipments and medical devices, research and development, manufacturing, sales, export/import for diagnosis technique, treatment approach and cultural method for gene and cell, research and development, research by commissioning, and technical consultation for cell therapy, rehabilitation, and medical products, research and development, manufacturing, sales, export/import, and rental of device and equipment for cell therapy, rehabilitation, and medical products, research and development and sales of computer system for cell therapy, educational enterprise for human resource development, and consulting service of planning and operating for human resource development.
Specifically, manufactures Gravite. Gravite is a multi-directional gravity device for simulating microgravity. By controlled rotation of two axes, a 3D-clinostat minimizes the cumulative gravity vector at the center of the device and makes 10-3G over time average. Moreover, Gravite® creates not only simulated microgravity environment as well as ISS but also hyper-gravity environment of 2-3G by centrifugal force from one axis rotation. Gravite could help your research for regenerative medicine, space biology, drug discovery, and so on.
Space Bio-Lab also produces Re-Gait, a walking support robot. Rehabilitation is the most important treatment to accelerate recovery of neural function.
Space Bio-lab is developing a normal gait programmed walking support robot with Dr. Yuge, Hiroshima University, and Dr. Tanaka, Waseda University. “RE-Gait®” supports ankle dorsiflexion to stretch gastrocnemius, which induces reflex muscle contraction of knee and hip joint to step forward the leg smoothly. When the user pushes off with their toes to start walking, RE-Gait® supports ankle plantarflexion smoothly. When the user's heel contacts the ground, RE-Gait® supports ankle dorsiflexion to prevent stumbling.

In 2005, Space Bio-Laboratories Y.K. was established. In 2011, Space Bio-Laboratories Y.K. changed its name to Space Bio-Laboratories Co.,Ltd.

## Funding rounds

- Series A, Jun 24, 2020, $0.9M — Hiroshima Venture Capital, RORZE Corporation

## Investors

- Hiroshima Venture Capital (https://capitalatlas.ai/funds/hiroshima-venture-capital) — Series A
- RORZE Corporation — Series A